Supply of Albuterol Sulfate Inhalation Aerosol (HFA) – Packaged Medical Product

The contract entails the full-scale manufacture, packaging, marking, and delivery of Albuterol Sulfate Inhalation Aerosol in metered-dose inhaler form, pressurized with hydrofluoroalkane (HFA), adhering strictly to both military and pharmaceutical regulatory standards. The product must meet exacting specifications for consistency, efficacy, and safety, ensuring suitability for use in Department of Defense medical operations. All phases of production, from active pharmaceutical ingredient processing to final unit packaging and labeling, are subject to rigorous quality control protocols to guarantee compliance with federal and defense medical requirements. The place of performance is designated as Fort Campbell, with a delivery address of 42223-5000, indicating the primary logistics hub for distribution. The solicitation is classified as a subcontract under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing, and was posted on May 4, 2026, with responses due by May 11, 2026. The contracting authority is the Medical Supply Chain Pharm FSA under the Department of Defense, underscoring the mission-critical nature of the supply. Although no specific set-aside designation is identified, the requirement is intended for qualified contractors capable of fulfilling strict military-grade pharmaceutical delivery commitments under tight timelines.